Dual-phase zwitterionic monomers
Abstract
Hydrogel materials used in the manufacture of biocompatible medical devices, for example, hydrogel materials having desirable physical properties for use as a contact lens. A composition contains at least one vinyl containing monomer, a methacrylate(acrylate) monomer, methacrylate (acrylate) prepolymers, crosslinking agents and monomers having the structure as shown in Formula 1:where R1 is a vinyl functionality capable of radical polymerization with specific preference for N-vinyl lactam derivatives and R2 is a zwitterionic functionality. The materials utilize a two-phase polymerization strategy.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition comprising a monomer having the structure as shown in Formula
wherein:
R 1 is selected from the group as shown below in formulas (II)-(VIII):
wherein Y 1 and Y 2 are independent of one other and each on of Y1 and Y2 is a linkage selected from the group consisting of a direct bond, C 1 -C 6 divalent radical, O, NW, C(O), C(O)NR a , NR a C(O), OC(O)NH, NHC(O)O, NR a C(O)NH, NHC(O)NR a , C(O)O, OC(O), NHC(O)NHZ 0 —NH—C(O)NH, OC(O)NHZ 0 —NH—C(O)O, OC(O)NHZ 0 —NH—C(O)NH, and NHC(O)NHZ 0 —NH—C(O)O; where R a is H, C 1 -C 4 alkyl or C 1 -C 3 alkanol, and Z 0 is a linear or branched C 2 -C 12 alkylene divalent radical, or a C 5 -C 7 cycloaliphatic divalent radical;
wherein Z 1 is selected from the group consisting of a direct bond, a C 1 -C 12 unsubstituted or substituted, linear or branched alkylene divalent radical, an unsubstituted phenylene divalent radical, a C 5 -C 7 cycloaliphatic divalent radical, and a C 7 -C 12 arylalkylene divalent radical, wherein at least two of the groups Y 1 , Y 2 , Z 1 and Z 2 is not a direct bond,
wherein R 2 for formulas II-VII is selected from the group of zwitterionic functionality as shown in the following formulas:
where R is selected from the group consisting of a direct bond, C 1 -C 6 divalent radical, O, NR a , C(O), C(O)NR a , NR a C(O), OC(O)NH, NHC(O)O, NR a C(O)NH, NHC(O)NR a , C(O)O, OC(O), NHC(O)NHZ 0 —NH—C(O)NH, OC(O)NHZ 0 —NH—C(O)O, OC(O)NHZ 0 —NH—C(O)NH, and NHC(O)NHZ 0 —NH—C(O)O; where R a is H, C 1 -C 4 alkyl or C 1 -C 3 alkanol, and Z 0 is a linear or branched C 2 -C 12 alkylene divalent radical, or a C 5 -C 7 cycloaliphatic divalent radical;
wherein in the case of the structure VIII, R 2 is selected from the following anionic groups to provide a zwitterionic monomer capable of cyclo-copolymerizing:
where R is selected from the group consisting of a direct bond, C 1 -C 6 divalent radical, O, NR a , C(O), C(O)NR a , NR a C(O), OC(O)NH, NHC(O)O, NR a C(O)NH, NHC(O)NR a , C(O)O, OC(O), NHC(O)NHZ 0 —NH—C(O)NH, OC(O)NHZ 0 —NH—C(O)O, OC(O)NHZ 0 —NH—C(O)NH, and NHC(O)NHZ 0 —NH—C(O)O; where R a is H, C 1 -C 4 alkyl or C 1 -C 3 alkanol, and Z 0 is a linear or branched C 2 -C 12 alkylene divalent radical, or a C 5 -C 7 cycloaliphatic divalent radical.
2 . The composition of claim 1 further comprising at least one vinyl monomer selected from the group consisting of N-vinyl-2-pyrrolidone, N-vinyl piperidone, N-vinyl-caprolactam, N-vinylimidazolidone, N-vinylsuccinimide, N-vinylformamide, N-vinyl urea, N-vinylcarbamate, O-vinyl carbonate and any one mixture thereof.
3 . The composition of claim 1 , further comprising at least one (meth)acrylic monomer.
4 . The composition of claim 3 , wherein the (meth)acrylic monomer is 4-t-butyl-2-hydroxycyclohexylmethacrylate or another cycloaliphatic strengthening agents.
5 . The composition of claim 3 , wherein the(meth)acrylic monomers include functional monomers selected from the group consisting of carboxybetaines, sulfobetaines and phosphobetaines.
6 . The composition of claim 1 further comprising silicone monomers selected from the group consisting of Tris-(trimethylsiloxy)-3-methacryloxypropyl methacrylate (Tris), 3-methacryloxy-2-hydroxypropyloxy) propylbis(trimethylsiloxy)-methylsilane (Sigma), and other siloxy silane monomers, and mixture thereof, wherein the mixture thereof is present from 8% to 60% by weight of the composition.
7 . The composition of claim 1 further comprising silicone prepolymers selected from the group consisting of mono or difunctional polydimethyl siloxanes and mixtures thereof present from 8% to 60% by weight of the composition.
8 . The composition of claim 1 , wherein Z 1 is a branched alkylene divalent radical that includes one or more linkages of O, NR a , and C(O).
9 . The composition of claim 1 , further comprising a crosslinking agent.
10 . A hydrogel polymer prepared from the composition of claim 1 .
11 . The hydrogel polymer of claim 10 with a water content of 30 to 90 wt percent.
12 . A contact lens prepared with the hydrogel polymer according to claim 10 .Join the waitlist — get patent alerts
Track US2024026049A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.